Flip the concept of biological detection with optical sensing, Netge Biotech FOPPR creates a win-win vision
Jul 21, 2021
The founder and CEO of Naijie Biotech, Zhong, Zun-zhi and two professors from Chung Cheng University, Zhou, Li-jun and Wang, Shao-jun, jointly established Naijie Biotech in August 2016. The two professors' "FOPPR" research has extremely high commercial value. Naijie sees the trend of biotechnology companies and pharmaceutical manufacturers investing in the development of antibody drugs. They hoping to provide clinicians with more accurate, fast and simple detection solutions. It is used as the basis for disease monitoring of patients and evaluation of drug efficacy after drug treatment. "FOPPR", which flips the existing thinking of the medical testing industry, has attracted the attention of international manufacturers. The Merck Innovation Center under the well-known German pharmaceutical company Merck KGaA, Naijie Biotechnology has drawn from more than 500 start-up teams around the world. Stand out and become the only selected strategic partner in Asia in 2020, and will enter the accelerator in 2021 to communicate with local experts. Currently, strategic cooperation projects have been launched.
標籤：Flip the concept of biological detection with optical sensing, Netge Biotech FOPPR creates a win-win vision